Evidence map›Paper›PMID 36962231›Full record

ArticlePLOS global public health2022

Epidemiological factors associated with HBV infection and uptake of testing in south west region of Cameroon: What can be done to scale up HBV testing in our setting?

Henry Dilonga Meriki, Kukwah Anthony Tufon, Teuwafeu Denis Georges, Ngomba Divine Martin Mokake, Ronald Mbua Gobina, Nyeke James Tony, Tebit Emmanuel Kwenti, Ayah Flora Bolimo, Malika Esembeson, Nkouonlack Cyrille and 5 more

Open access · goldFull text read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Henry Dilonga MerikiDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.ORCID https://orcid.org/0000-0002-9148-0171
Kukwah Anthony TufonDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.ORCID https://orcid.org/0000-0002-5643-0515
Teuwafeu Denis GeorgesBuea Regional Hospital, Buea, Southwest Region, Cameroon.ORCID https://orcid.org/0000-0002-7128-2733
Ngomba Divine Martin MokakeBuea Regional Hospital, Buea, Southwest Region, Cameroon.
Ronald Mbua GobinaBuea Regional Hospital, Buea, Southwest Region, Cameroon.ORCID https://orcid.org/0000-0002-1810-3716
Nyeke James TonyDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.ORCID https://orcid.org/0000-0003-1191-3502
Tebit Emmanuel KwentiDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.
Ayah Flora BolimoDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.
Malika EsembesonBuea Regional Hospital, Buea, Southwest Region, Cameroon.
Nkouonlack CyrilleBuea Regional Hospital, Buea, Southwest Region, Cameroon.ORCID https://orcid.org/0000-0002-4455-6532
Fokam Djike Puepi YolandeBuea Regional Hospital, Buea, Southwest Region, Cameroon.ORCID https://orcid.org/0000-0003-4463-6409
Iyah Rebecca ItoeDepartment of Microbiology and Parasitology, University of Buea, Buea, South West Region, Cameroon.
Tsamul BeltineBuea Regional Hospital, Buea, Southwest Region, Cameroon.
Theresa Nkuo-AkenjiDepartment of Biological Science, Faculty of Science, University of Bamenda, Bamenda, North West Region, Cameroon.
Damian Nota AnongDepartment of Biological Science, Faculty of Science, University of Bamenda, Bamenda, North West Region, Cameroon.ORCID https://orcid.org/0000-0003-4677-1495
University of Buea · CMUniversity of Bamenda · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B infection affects millions of people globally, partly due to its high degree of transmissibility and asymptomatic nature. This study was aimed at identifying prevailing epidemiological factors associated with HBV infection and testing uptake in the South West region of Cameroon. This hospital-based case-control study enrolled HBV infected participants and "healthy" controls ≥18 years old. Venous blood collected from participants was used to conduct HBV panel test (HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc). Data on demographic and behavioral risk factors as well as reasons for taking the HBV test for the first time were collected using a questionnaire. A total of 424 participants were enrolled (212 "healthy" controls and 212 HBV infected cases). Male sex (odds ratio [OR] = 2.08, p = 0.010), ≤ secondary education level (OR = 4.83, p<0.001), low-income level (OR = 3.79, p<0.001), rural settlement (OR = 2.17, p = 0.031), history of sexually transmitted infections (STI) (OR = 4.24, p<0.001) and ignorance of sexual partners HBsAg status (OR = 2.70, p = 0.003) all had an independent and significant association with HBV infection. Top 3 reasons for doing HBsAg test were free screening (40.3%), blood donation (15.0%) and administrative requirements (14.9%). HBV testing uptake and early detection can be improved if more sensitization and free/opportunistic screenings are implemented. A significant drop in the cost of HBV test could encourage more people to get tested.

Identifiers

PMID36962231
PMCPMC10021278
OpenAlexW4280591514

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read20
identifiers read5
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.